Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules

Abstract

MPTX test status accurately stratifies patients for risk of malignancy. Further classification using MPTX clinical risk categories enhances utility by accurately identifying patients at low, moderate, or high risk of malignancy at the low rate of malignancy encountered when clinically managing patients with indeterminate thyroid nodules.